Table: Zeria Pharm - 9-MTH group results

Zeria Pharmaceutical

01/02/2024 07:00

Feb 1 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             57.92               51.73            73.00    
                 (+12.0 pct)         (+14.7 pct)      (+6.8 pct)  
  Operating          9.49                8.55             9.10    
                 (+11.0 pct)         (+55.6 pct)      (+0.9 pct)  
  Recurring          9.44                6.96             9.00    
                 (+35.7 pct)         (+24.0 pct)      (+18.7 pct) 
  Net                8.42                5.98             7.00    
                 (+40.8 pct)         (+47.9 pct)      (+13.0 pct) 
  EPS            191.09 yen          135.31 yen       158.80 yen  
  Ann Div                             40.00 yen        44.00 yen  
  -Q2 div         22.00 yen           18.00 yen                   
  -Q4 div                             22.00 yen        22.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T